| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Experimental Therapeutics, Preclinical Pharmacology |
Departments of 1 Medicine and 2 Neurology, University of California Los Angeles, Los Angeles, California and 3 Armagen Technologies, Inc., Santa Monica, California
ABSTRACT
Purpose: The human epidermal growth factor receptor (EGFR) plays an oncogenic role in solid cancer, including brain cancer. The present study was designed to prolong survival in mice with intracranial human brain cancer with the weekly i.v. injection of nonviral gene therapy causing RNA interference (RNAi) of EGFR gene expression.
Experimental Design: Human U87 gliomas were implanted in the brain of adult scid mice, and weekly i.v. gene therapy was started at day 5 after implantation of 500,000 cells. An expression plasmid encoding a short hairpin RNA directed at nucleotides 2529–2557 within the human EGFR mRNA was encapsulated in pegylated immunoliposomes. The pegylated immunoliposome was targeted to brain cancer with 2 receptor-specific monoclonal antibodies (MAb), the murine 83–14 MAb to the human insulin receptor and the rat 8D3 MAb to the mouse transferrin receptor.
Results: In cultured glioma cells, the delivery of the RNAi expression plasmid resulted in a 95% suppression of EGFR function, based on measurement of thymidine incorporation or intracellular calcium signaling. Weekly i.v. RNAi gene therapy caused reduced tumor expression of immunoreactive EGFR and an 88% increase in survival time of mice with advanced intracranial brain cancer.
Conclusions: Weekly i.v. nonviral RNAi gene therapy directed against the human EGFR is a new therapeutic approach to silencing oncogenic genes in solid cancers. This is enabled with a nonviral gene transfer technology that delivers liposome-encapsulated plasmid DNA across cellular barriers with receptor-specific targeting ligands.
This article has been cited by other articles:
|
|
 |
|
  E. Arwert, S. Hingtgen, J.-L. Figueiredo, H. Bergquist, U. Mahmood, R. Weissleder, and K. Shah Visualizing the Dynamics of EGFR Activity and Antiglioma Therapies In vivo Cancer Res., August 1, 2007; 67(15): 7335 - 7342. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Jagannath and M. Wood RNA interference based gene therapy for neurological disease Brief Funct Genomic Proteomic, May 3, 2007; (2007) elm005v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. M. Martineau and I. T. Pyrah Invited Review: Review of the Application of RNA Interference Technology in the Pharmaceutical Industry Toxicol Pathol, April 1, 2007; 35(3): 327 - 336. [Abstract] [PDF]
|
|
|
|
 |
|
 A. K. Murashov, V. Chintalgattu, R. R. Islamov, T. E. Lever, E. S. Pak, P. L. Sierpinski, L. C. Katwa, and M. R. Van Scott RNAi pathway is functional in peripheral nerve axons FASEB J, March 1, 2007; 21(3): 656 - 670. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-A. Zhang, J. Nemunaitis, S. K. Samuel, P. Chen, Y. Shen, and A. W. Tong Antitumor Activity of an Oncolytic Adenovirus-Delivered Oncogene Small Interfering RNA Cancer Res., October 1, 2006; 66(19): 9736 - 9743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Bora, S. Kaliappan, P. Jha, Q. Xu, J.-H. Sohn, D. B. Dhaulakhandi, H. J. Kaplan, and P. S. Bora Complement Activation via Alternative Pathway Is Critical in the Development of Laser-Induced Choroidal Neovascularization: Role of Factor B and Factor H J. Immunol., August 1, 2006; 177(3): 1872 - 1878. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Jha, J.-H. Sohn, Q. Xu, Y. Wang, H. J. Kaplan, P. S. Bora, and N. S. Bora Suppression of Complement Regulatory Proteins (CRPs) Exacerbates Experimental Autoimmune Anterior Uveitis (EAAU). J. Immunol., June 15, 2006; 176(12): 7221 - 7231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Pulukuri, C. S. Gondi, S. S. Lakka, A. Jutla, N. Estes, M. Gujrati, and J. S. Rao RNA Interference-directed Knockdown of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor Inhibits Prostate Cancer Cell Invasion, Survival, and Tumorigenicity in Vivo J. Biol. Chem., October 28, 2005; 280(43): 36529 - 36540. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hu-Lieskovan, J. D. Heidel, D. W. Bartlett, M. E. Davis, and T. J. Triche Sequence-Specific Knockdown of EWS-FLI1 by Targeted, Nonviral Delivery of Small Interfering RNA Inhibits Tumor Growth in a Murine Model of Metastatic Ewing's Sarcoma Cancer Res., October 1, 2005; 65(19): 8984 - 8992. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Li, X. Lin, M. Staver, A. Shoemaker, D. Semizarov, S. W. Fesik, and Y. Shen Evaluating Hypoxia-Inducible Factor-1{alpha} as a Cancer Therapeutic Target via Inducible RNA Interference In vivo Cancer Res., August 15, 2005; 65(16): 7249 - 7258. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Fisher Wilson Gene Therapy Yields to RNA Interference Ann Intern Med, July 19, 2005; 143(2): 161 - 164. [Full Text] [PDF]
|
|
|
|
|
|
A. Jimeno, B. Rubio-Viqueira, M. L. Amador, D. Oppenheimer, N. Bouraoud, P. Kulesza, V. Sebastiani, A. Maitra, and M. Hidalgo Epidermal Growth Factor Receptor Dynamics Influences Response to Epidermal Growth Factor Receptor Targeted Agents Cancer Res., April 15, 2005; 65(8): 3003 - 3010. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Shankar, N. Manjunath, and J. Lieberman The Prospect of Silencing Disease Using RNA Interference JAMA, March 16, 2005; 293(11): 1367 - 1373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. M. Schiffelers, A. Ansari, J. Xu, Q. Zhou, Q. Tang, G. Storm, G. Molema, P. Y. Lu, P. V. Scaria, and M. C. Woodle Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle Nucleic Acids Res., November 1, 2004; 32(19): e149 - e149. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
